06/25/2025
3:02 PM | Immunovant (Subject)
Macias William L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025
4:34 PM | Immunovant (Subject)
Macias William L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2025
4:42 PM | Immunovant (Subject)
Macias William L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2025
6:14 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
6:30 AM | Immunovant (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/21/2025
3:24 PM | Immunovant (Subject)
MIGAUSKY GEORGE V (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025
6:30 PM | Immunovant (Issuer)
Susman Robert Graham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
6:30 PM | Bauer Jake (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
6:30 PM | Girao Tiago (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
4:01 PM | Immunovant (Issuer)
Susman Robert Graham (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/28/2025
4:02 PM | Bauer Jake (Reporting)
Immunovant (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for IMVT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Immunovant and its competitors with MarketBeat's FREE daily newsletter. |
04/28/2025
4:03 PM | Girao Tiago (Reporting)
Immunovant (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/21/2025
6:18 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
6:54 AM | Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
04/17/2025
3:07 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
3:08 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
3:05 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:50 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:51 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:53 PM | Gloria Melanie (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:55 PM | Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:41 PM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:43 PM | Hughes Douglas J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:44 PM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:46 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:48 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:37 PM | Immunovant (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
6:51 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
3:18 PM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:17 PM | Fromkin Andrew J. (Reporting)
Immunovant (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
9:01 AM | FMR LLC (Filed by)
Immunovant (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
5:45 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/06/2025
5:37 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
4:20 PM | Immunovant (Filer)
| Form 424B3 | |
01/24/2025
4:24 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:22 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:23 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
4:16 PM | Immunovant (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/15/2025
3:36 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:30 PM | Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
01/14/2025
7:09 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad) Michael Robinson has been at the forefront of the technology market for over 40 years.
Spotting some profitable trends in tech … well ahead of Wall Street.
Like when he called Nvidia at a mere 80 cents a share.
Or Bitcoin when it was trading for just $300.
Throughout his illustrious career …
Michael has given his followers almost 150 different chances to register triple-digit gains. Now he's identified his next potential winner. Click here to find out more. |
01/13/2025
7:07 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:01 PM | Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/18/2024
4:02 PM | Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:11 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:12 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:09 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:08 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
4:11 PM | Gloria Melanie (Reporting)
Immunovant (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2024
4:15 PM | Gloria Melanie (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:42 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
5:49 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
3:21 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:23 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:25 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:27 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:28 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:30 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:31 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
6:40 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:15 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:12 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:19 PM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
3:17 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:19 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:20 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:36 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:38 PM | Butchko Julia G. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:39 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:41 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:42 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
